181 related articles for article (PubMed ID: 11006034)
21. Stat3 dimerization regulated by reversible acetylation of a single lysine residue.
Yuan ZL; Guan YJ; Chatterjee D; Chin YE
Science; 2005 Jan; 307(5707):269-73. PubMed ID: 15653507
[TBL] [Abstract][Full Text] [Related]
22. STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
[TBL] [Abstract][Full Text] [Related]
23. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
24. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
Gagarin D; Yang Z; Butler J; Wimmer M; Du B; Cahan P; McCaffrey TA
J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468
[TBL] [Abstract][Full Text] [Related]
25. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
Chen H; Ye D; Xie X; Chen B; Lu W
Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
[TBL] [Abstract][Full Text] [Related]
26. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract][Full Text] [Related]
27. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters.
Stephanou A; Brar BK; Knight RA; Latchman DS
Cell Death Differ; 2000 Mar; 7(3):329-30. PubMed ID: 10866494
[No Abstract] [Full Text] [Related]
28. STATs in oncogenesis.
Bowman T; Garcia R; Turkson J; Jove R
Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
31. [Significance of phosphorylation of mitogen-activated protein kinase and signal transducer and activator of transcription 3 and cyclin D1 protein expression in Hodgkin's lymphomas].
Luo HY; Wang HC; Li YN; Zheng H
Ai Zheng; 2003 Mar; 22(3):266-9. PubMed ID: 12654183
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
Masuda M; Suzui M; Lim JT; Weinstein IB
Clin Cancer Res; 2003 Aug; 9(9):3486-91. PubMed ID: 12960141
[TBL] [Abstract][Full Text] [Related]
33. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
34. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
36. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.
Paner GP; Silberman S; Hartman G; Micetich KC; Aranha GV; Alkan S
Anticancer Res; 2003; 23(3B):2253-60. PubMed ID: 12894500
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
[TBL] [Abstract][Full Text] [Related]
38. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.
Zhang F; Li C; Halfter H; Liu J
Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell anchorage.
Lin HM; Lee YJ; Li G; Pestell RG; Kim HR
Cell Death Differ; 2001 Jan; 8(1):44-50. PubMed ID: 11313702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
